June 12, 2017 by Chain Drug Review
Competition Bureau of Canada, Katz Group Canada, McKesson, Rexall drug stores, Rexall Health, Rx Drug Mart, Uniprix
Business, Leading Headlines, Retail News

OTTAWA — McKesson Corp. is selling 27 Rexall drug stores to Rx Drug Mart Inc. under a consent agreement with the Competition Bureau of Canada for its $2.2 billion acquisition of Rexall Health. The Competition Bureau said Friday that it has approved Rx Drug Mart, a Toronto-based independent pharmacy network, as the buyer of the
December 14, 2016 by Chain Drug Review
Competition Bureau of Canada, Katz Group Canada, McKesson, Paul Julian, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO — McKesson Corp. has been given the green light from the Competition Bureau of Canada to finalize its $2.2 billion acquisition of drug chain Rexall Health. McKesson said Wednesday that under the consent agreement it signed with the bureau, it must sell a total of 26 Rexall drug stores in Alberta, British Columbia,
May 29, 2015 by Chain Drug Review and Chain Drug Review
Katz Group Canada, Rexall, Ritchie Bros., Sharon Driscoll
Business, Leading Headlines, Retail News

VANCOUVER, British Columbia — Sharon Driscoll, executive vice president and chief financial officer at Rexall/Katz Group Canada Ltd., is leaving the company to join Ritchie Bros., an industrial equipment auctioneer. Ritchie Bros. said Friday that Driscoll is set to start at the company on July 6 as chief financial officer. Driscoll served as executive vice
May 26, 2015 by Chain Drug Review and Chain Drug Review
99 Cents Only Stores, Andy Giancamilli, Katz Group Canada, Stéphane Gonthier
Business, Leading Headlines, Retail News

CITY OF COMMERCE, Calif. — Andy Giancamilli, a former chief executive officer of Katz Group Canada Ltd. and past chairman of the National Association of Chain Drug Stores, has been named interim president and CEO of 99 Cents Only Stores. The extreme value store chain said late Tuesday that Giancamilli, its chairman, takes over from
January 31, 2012 by Chain Drug Review
Daryl Katz, Dell Pharmacies, Drug Trading Co., John Hammergren, Katz Group Canada, McKesson, Medicine Shoppe Canada, ProPharm, Rexall
Business, Retail News
TORONTO — Katz Group Canada has signed an agreement to sell Drug Trading Co., its banner pharmacy business, and Medicine Shoppe Canada, its franchise pharmacy business, to McKesson Corp. for about $920 million. As part of the transaction McKesson is entering into other ancillary agreements with Katz Group. Both Drug Trading and Medicine Shoppe Canada